Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/145402
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lio, Daniel Chin Shiuan | en_US |
dc.contributor.author | Chia, Ruining | en_US |
dc.contributor.author | Kwek, Milton Sheng Yi | en_US |
dc.contributor.author | Wiraja, Christian | en_US |
dc.contributor.author | Madden, Leigh Edward | en_US |
dc.contributor.author | Chang, Hao | en_US |
dc.contributor.author | S. Mohideen Abdul Khadir | en_US |
dc.contributor.author | Wang, Xiaomeng | en_US |
dc.contributor.author | Becker, David Lawrence | en_US |
dc.contributor.author | Xu, Chenjie | en_US |
dc.date.accessioned | 2020-12-21T04:00:17Z | - |
dc.date.available | 2020-12-21T04:00:17Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Lio, D. C. S., Chia, R., Kwek, M. S. Y., Wiraja, C., Madden, L. E., Chang, H., . . . Xu, C. (2020). Temporal pressure enhanced topical drug delivery through micropore formation. Science Advances, 6(22), eaaz6919-. doi:10.1126/sciadv.aaz6919 | en_US |
dc.identifier.issn | 2375-2548 | en_US |
dc.identifier.uri | https://hdl.handle.net/10356/145402 | - |
dc.description.abstract | Transdermal drug delivery uses chemical, physical, or biochemical enhancers to cross the skin barrier. However, existing platforms require high doses of chemical enhancers or sophisticated equipment, use fragile biomolecules, or are limited to a certain type of drug. Here, we report an innovative methodology based on temporal pressure to enhance the penetration of all kinds of drugs, from small molecules to proteins and nanoparticles (up to 500 nm). The creation of micropores (~3 μm2) on the epidermal layer through a temporal pressure treatment results in the elevated expression of gap junctions, and reduced expression of occludin tight junctions. A 1 min treatment of 0.28-MPa allows nanoparticles (up to 500 nm) and macromolecules (up to 20 kDa) to reach a depth of 430-μm into the dermal layer. Using, as an example, the delivery of insulin through topical application after the pressure treatment yields up to 80% drop in blood glucose in diabetic mice. | en_US |
dc.description.sponsorship | Agency for Science, Technology and Research (A*STAR) | en_US |
dc.description.sponsorship | National Medical Research Council (NMRC) | en_US |
dc.description.sponsorship | Skin Research Institute of Singapore (SRIS) | en_US |
dc.language.iso | en | en_US |
dc.relation | A18A8b0059 | en_US |
dc.relation | H18/01/a0/0I9 | en_US |
dc.relation | H17/01/a0/0C9 | en_US |
dc.relation | H17/01/a0/004 | en_US |
dc.relation | NMRC/OFLCG/001/2017 | en_US |
dc.relation | NMRC/OFLCG/004/2018 | en_US |
dc.relation.ispartof | Science Advances | en_US |
dc.rights | © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). | en_US |
dc.subject | Science::Medicine | en_US |
dc.title | Temporal pressure enhanced topical drug delivery through micropore formation | en_US |
dc.type | Journal Article | en |
dc.contributor.school | School of Chemical and Biomedical Engineering | en_US |
dc.contributor.school | Interdisciplinary Graduate School (IGS) | en_US |
dc.contributor.school | Lee Kong Chian School of Medicine (LKCMedicine) | en_US |
dc.contributor.research | NTU Institute for Health Technologies | en_US |
dc.identifier.doi | 10.1126/sciadv.aaz6919 | - |
dc.description.version | Published version | en_US |
dc.identifier.pmid | 32523993 | - |
dc.identifier.issue | 22 | en_US |
dc.identifier.volume | 6 | en_US |
dc.subject.keywords | Chemical Equipment | en_US |
dc.subject.keywords | Drug Dosage | en_US |
dc.description.acknowledgement | C.X. acknowledges the funding support from Singapore Agency for Science, Technology and Research (A*STAR) Science and Engineering Research Council Additive Manufacturing for Biological Materials (AMBM) program (A18A8b0059) and internal grant from City University of Hong Kong (#9610472). D.L.B. acknowledges the funding support from A*STAR under its Industry Alignment Fund–Pre-Positioning Programme (IAF-PP): (1) Wound Care Innovation for the Tropics Programme, Singapore (WCIT): (H18/01/a0/0I9) and (H17/01/a0/0C9); (2) The Skin Research Institute of Singapore, Phase 2: SRIS@Novena (“IAF-PP SRIS2 Grant”, H17/01/a0/004). X.W. acknowledges the funding support from the National Medical Research Council Singapore Large Collaborative Grant DYNAMO (NMRC/OFLCG/001/2017); and National Medical Research Council Singapore Large Collaborative Grant TAAP (NMRC/OFLCG/004/2018). | en_US |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
Appears in Collections: | SCBE Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Science Journals — AAAS - eaaz6919.full.pdf | 7.43 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
20
10
Updated on Mar 24, 2023
Web of ScienceTM
Citations
20
10
Updated on Mar 26, 2023
Page view(s)
283
Updated on Mar 29, 2023
Download(s) 50
56
Updated on Mar 29, 2023
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.